<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04643197</url>
  </required_header>
  <id_info>
    <org_study_id>KGOG 4001</org_study_id>
    <nct_id>NCT04643197</nct_id>
  </id_info>
  <brief_title>Effect of Barbed Suture Fascia Closure on Incisional Hernia in Midline Laparotomy for Gynecological Diseases (BARBHER)</brief_title>
  <acronym>BARBHER</acronym>
  <official_title>Effects of Barbed Suture Fascia Closure on Incisional Hernia in Midline Laparotomy for Gynecological Disease (BARBHER)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Investigators will compare the incidence of incisional hernia in women who underwent midline&#xD;
      laparotomy whose abdominal fascia was closed with barbed suture vs. conventional non-barbed&#xD;
      suture.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 1, 2020</start_date>
  <completion_date type="Anticipated">May 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">May 30, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <intervention_model_description>2*2 factorial design Primary randomization: Barbed suture vs. Non-barbed suture in fascia closure Secondary randomization: subcutaneous drain insertion vs. non-insertion The effect of secondary randomization is one of secondary objectives.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cumulative incidence of incisional hernia</measure>
    <time_frame>from surgery to 1 year</time_frame>
    <description>Incisional hernia till 1 year after surgery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time-event curve of incisional hernia</measure>
    <time_frame>from surgery to 1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cumulative incidence of surgical site infection</measure>
    <time_frame>from surgery to 4weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of wound dehiscence</measure>
    <time_frame>post-surgery 4weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Brief Pain Inventory - Korean (BPI-K) score</measure>
    <time_frame>Baseline, postoperative day 2, 4</time_frame>
    <description>Pain measured with BPI-K Specifically score (0-10 all domain, higher score mean worse outcome) in domain of worst pain, least pain, average pain, current pain, impact of pain in general activity, mood, work, relationship, ambulation, sleep and happiness</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Treatment related adverse event</measure>
    <time_frame>from surgery to 1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>NRS</measure>
    <time_frame>from surgery to postoperative 4 day</time_frame>
    <description>pain captured by NRS in nursing record, 0-10, higher score means more pain</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">174</enrollment>
  <condition>Gynecologic Disease</condition>
  <arm_group>
    <arm_group_label>Experimental arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Abdominal fascia will be closed with barbed suture.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Abdominal fascia will be closed with non-barbed suture.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Barbed PDS suture (STRATAFIX Symmetric PDS Plus)</intervention_name>
    <description>STRATAFIX Symmetric PDS Plus is a barbed suture.</description>
    <arm_group_label>Experimental arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Non-barbed PDS suture (PDS Plus)</intervention_name>
    <description>Non-barbed suture</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Anticipating midline laparotomy for gynecologic diseases&#xD;
&#xD;
          -  ECOG performance status 0 - 2&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Previous or current abdominal incisional hernia&#xD;
&#xD;
          -  Pregnant&#xD;
&#xD;
          -  Previous radiation on abdomen area&#xD;
&#xD;
          -  Allergy to PDS or irgacare MP&#xD;
&#xD;
          -  Having disease affecting wound healing such as uncontrolled DM, autoimmune vasculitis,&#xD;
             liver cirrhosis, coagulopathy&#xD;
&#xD;
          -  BMI &gt; 35&#xD;
&#xD;
          -  Current or anticipated use of drugs affecting wound healing such as bevacizumab (with&#xD;
             4 week drug free period, bevacizumab user is eligible)&#xD;
&#xD;
          -  Abdominal midline laparotomy within 6 months&#xD;
&#xD;
          -  Surgery for infection control&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Kidong Kim</last_name>
    <phone>82 31 787 7262</phone>
    <email>kidong.kim.md@gmail.com</email>
  </overall_contact>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>November 11, 2020</study_first_submitted>
  <study_first_submitted_qc>November 23, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 25, 2020</study_first_posted>
  <last_update_submitted>November 23, 2020</last_update_submitted>
  <last_update_submitted_qc>November 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 25, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Bundang Hospital</investigator_affiliation>
    <investigator_full_name>Kidong Kim</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Incisional Hernia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

